MedPath

A clinical trial to study the effect of Pankajakasthuri Breath Eazy Mishrit, in patients with cough, cold and breathing difficulties.

Phase 1
Completed
Conditions
Health Condition 1: J454- Moderate persistent asthmaHealth Condition 2: J454- Moderate persistent asthmaHealth Condition 3: null- The Patients with Bronchial Asthma visiting PANKAJAKASTHURI AYURVEDA MEDICAL COLLEGE OUT PATIENT DEPARATMENTS for consultation.
Registration Number
CTRI/2016/10/007389
Lead Sponsor
Pankajakasthuri Ayurveda Medical College and Post Graduate Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Both sex with equal distributor with or without rhinitis.

3 Mild persistent cases of Asthma (as per WHO GINA Guideline) of duration more than 6 months.

Asthmatic meet reversibility criteria (15% improvement in FEVI after Beta â?? 2 agonist inhalation)

5

Exclusion Criteria

Mild intermittent, moderate persistent, severe persistent to severe Asthma (As per WHO GINA guidlines of duration more than 6 months)

Dyspnoea due to other disease like Left ventricular failure, COPD (Chronic Bronchitis, Emphysema), Upper respiratory tract obstruction, Bronchiectasis, cases of tuberculosis, interstitial lung disease/occupational Lung disease, tropical pulmonary eosinophilia, Lofflers disease & Allergic Bronchopulmonary Aspergillosis etc.

Diabetes Mellitus and Hypertension.

Severe renal/Hepatic disease

HIV positive cases

Lung Cancer

Pregnant/lactating mother

Patient who need Salbutamol inhaler daily.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.